Drug Delivery Scientists are key innovators in the pharmaceutical industry, specializing in developing systems that ensure drugs are effectively delivered to the right place in the body at the right time. Their work focuses on optimizing the pharmacokinetics and pharmacodynamics of medications, ensuring that drugs are absorbed, distributed, and released in the body to maximize therapeutic effect. These experts design and develop novel drug delivery technologies, including nanoparticles, liposomes, hydrogels, and microneedles, to overcome biological barriers, such as the blood-brain barrier or gastrointestinal tract, that often limit the effectiveness of conventional drug formulations. Their research is essential in improving the bioavailability and patient compliance of both small molecules and biologics.
Collaboration is a core aspect of their role, as drug delivery scientists often work with multidisciplinary teams, including chemists, biologists, clinicians, and engineers, to develop new delivery systems. They conduct rigorous preclinical and clinical studies to assess the safety, stability, and efficacy of drug formulations. Additionally, these specialists are involved in optimizing controlled-release systems, enhancing targeted delivery, and minimizing side effects by ensuring drugs reach only the targeted tissues or cells. As the field of personalized medicine expands, drug delivery scientists are increasingly focused on tailoring drug delivery systems to individual patient needs, ultimately improving outcomes in areas such as cancer, gene therapy, and chronic disease management.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia